US 11091532
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor
granted A61KA61K2039/505A61K35/00
Quick answer
US patent 11091532 (T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor) held by AUTOLUS LIMITED expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AUTOLUS LIMITED
- Grant date
- Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K35/00, A61K38/1774, A61K40/11